Vitality Watch

Dossier clinicaltrials trial early 24-aug-2026
Small or early-phase human trial or pilot study

Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia

Key claim: A randomized, sham-controlled trial is testing whether blood-flow-restriction walking improves muscle strength and physical function (with secondary looks at muscle mass, vascular function, and quality of life) in chronic stroke patients with sarcopenia versus sham-BFR walking.

Abstract

Effects of Blood Flow Restriction Walking on Muscle Strength and Physical Function in Chronic Stroke Patients with Sarcopenia: A Randomized, Sham-Controlled Trial Primary Objective: To evaluate the effects of BFR walking on muscle strength and physical function in chronic stroke patients with sarcopenia, compared to sham-BFR walking.

Secondary Objective: (1) To explore the potential impact of BFR walking on muscle mass and vascular function in chronic stroke patients with sarcopenia. (2) To assess the influence of BFR walking on quality of life in chronic stroke patients with sarcopenia.

Why this matters

Blood flow restriction is one of the few training modalities with a plausible mechanistic route to hypertrophy at loads that frail or clinically compromised older adults can actually sustain, and stroke-related sarcopenia is a canonical case where standard resistance-training doses fail. A sham-controlled design addresses the specific critique that prior BFR trials confound cuff pressure with attention/expectancy, so even a protocol-stage entry marks where the evidence base is trying to harden. Until results land, this remains a trial-framing signal, not a readout.

Source

Link

Briefing card

Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia
Stage: trial early · clinicaltrials · 24-aug-2026

A randomized, sham-controlled trial is testing whether blood-flow-restriction walking improves muscle strength and physical function (with secondary looks at muscle mass, vascular function, and quality of life) in chronic stroke patients with sarcopenia versus sham-BFR walking.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06974461

build build 880 · 2bcef25 · 2026-11-18